# Vericel Corp

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v3 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Canonical entity | alpha:company:c941046d-77be-4485-9bde-9fd92c5b9cba |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/vericel-corp |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 22 |
| Claims under review | 1 |
| Evidence records | 3 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-09-26T04:46:07.501992+00:00 |
| Last reviewed | 2026-09-26T04:46:07.501992+00:00 |

## Identity

- Legal name: Vericel Corp
- Display name: Vericel Corp

## Leadership

- Robert L. Zerbe, M.D.: Chairman of the Board. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.
- Alan L. Rubino: Director. Valid from: 2026-03-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:3.
- Alan Post-graduate Kevin: Director. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:3.
- Bachelor’s Lisa: Director. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:3.
- Dominick Colangelo: Director, President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.
- Heidi Hagen: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.
- Kevin F. McLaughlin: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.
- Lisa Wright: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.
- Paul K. Wotton: Director. Valid from: 2026-03-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:3.
- Paul K. Wotton, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.
- Post-doctoral Dr. Zerbe Dominick: Director. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:3.
- Robert L. Zerbe: Director. Valid from: 2026-03-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:3.
- Steven C. Gilman: Director. Valid from: 2026-03-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:3.
- Therapeutics. Heidi: Director. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:3.
- Dominick Colangelo: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.
- Joe Mara: Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.
- Jonathan Hopper: Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.
- Michael Halpin: Chief Operating Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.
- Sean Flynn: Chief Legal Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Vericel Corp. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:1.

## Headquarters

- US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

## Entity Status

- Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:1.

## Published Fact

- US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:1.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/vericel-corp).
- alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:2: [SEC DEF 14A 0001308179-26-000094](https://www.sec.gov/Archives/edgar/data/887359/000130817926000094/vcel2026_def14a.htm).
- alpha:evidence:company:c941046d-77be-4485-9bde-9fd92c5b9cba:3: [DEF 14A vcel2026_def14a.htm](https://www.sec.gov/Archives/edgar/data/887359/000130817926000094/vcel2026_def14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/vericel-corp)
- [Public Markdown](https://registry.alpha.ac/companies/vericel-corp.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/vericel-corp)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/vericel-corp?format=jsonld)
- MCP resource: `alpha://companies/vericel-corp` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.